Bacillus subtilis CpgA (circularly permuted GTPase) is a ribosome assembly GTPase that has a secondary function as a metabolite proofreading enzyme.
Ankita J. Sachla +3 more
doaj +1 more source
Enas M Al-Khlifeh,1 Ibrahim S Alkhazi,2 Majed Abdullah Alrowaily,3 Mansoor Alghamdi,4 Malek Alrashidi,4 Ahmad S Tarawneh,5 Ibraheem M Alkhawaldeh,6 Ahmad B Hassanat5 1Department of Medical Laboratory Science, Al-Balqa Applied University, Al-salt, 19117 ...
Al-Khlifeh EM +7 more
doaj
Siti Norhawani Harun,1 Syafinaz Amin Nordin,2 Siti Salwa Abd Gani,3,4 Ahmad Fuad Shamsuddin,5,6 Mahiran Basri,7 Hamidon Bin Basri1 1Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia ...
Harun SN +5 more
doaj
Failure of endophthalmitis prophylaxis: laboratory model comparing antibiotics and bacterial loads. [PDF]
Moon M +4 more
europepmc +1 more source
Identification of Antibacterial Hits Associated with Penicillin-Binding Protein 2 in <i>Escherichia coli</i> Using a Comprehensive Property Spectrum and Fivefold Maximum Drug-Likeness Strategy. [PDF]
Zhu H, Du S, Yang Q, Xu L, Shi W.
europepmc +1 more source
Layer-Specific Retinal Perfusion as a Personalized Biomarker: Evaluating the Subclinical Microanatomical Effects of Intracameral Cefuroxime After Routine Cataract Surgery. [PDF]
Wang CY, Cheng CY, Peng YJ.
europepmc +1 more source
Comprehensive analysis of cefuroxime-associated adverse events: Insights from JADER database (2004-2024) and comparison with FAERS database. [PDF]
Li F, Luo J, Zhang X, Jiang C, Xia G.
europepmc +1 more source
A prospective randomized study comparing amoxycillin/clavulanate (augmentin) with cefuroxime-metronidazole as prophylaxis in gynaecological surgery. [PDF]
Soni S, Rathore P, Tiwari A.
europepmc +1 more source
Uncovering the mechanisms of clinically relevant altered antibiotic responses of <i>Staphylococcus aureus</i> under wound infection-mimetic conditions. [PDF]
Rieger CD +3 more
europepmc +1 more source
A Fivefold Maximum Drug-Likeness Strategy for Prioritizing Antibacterial Candidates Against <i>Escherichia coli</i>. [PDF]
Zhu H, Du S, Yang Q, Xu L, Shi W.
europepmc +1 more source

